Merck Total Non-Operating Income/Expense 2010-2024 | MRK

Merck total non-operating income/expense for the twelve months ending September 30, 2024 was $-0.440B, a 37.59% decline year-over-year.

  • Merck annual total non-operating income/expense for 2023 was $-1.065B, a 42.06% decline from 2022.
  • Merck annual total non-operating income/expense for 2022 was $-1.838B, a 370.29% decline from 2021.
  • Merck annual total non-operating income/expense for 2021 was $0.68B, a 115.87% increase from 2020.

Merck Total Non-Operating Income/Expense 2010-2024 | MRK

  • Merck annual total non-operating income/expense for 2023 was $-1.065B, a 42.06% decline from 2022.
  • Merck annual total non-operating income/expense for 2022 was $-1.838B, a 370.29% decline from 2021.
  • Merck annual total non-operating income/expense for 2021 was $0.68B, a 115.87% increase from 2020.